Common Contracts
1 similar Research and Development Collaboration Agreement contracts
Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development CollaborationResearch and Development Collaboration Agreement • January 13th, 2020
Current methods used to diagnose AD remain invasive and relatively complex. Therefore, there is a need to develop and establish reliable, less invasive and efficient biomarkers and technologies in clinical practice. To address this, Nordic Bioscience has been pioneering the development of blood-based biomarkers for decades and is therefore the ideal partner for identifying molecular fingerprints in blood of patients. This supports Vivoryon’s therapeutic approach of targeting neurotoxic pGlu-Abeta by inhibiting its producing enzyme Glutaminyl Cyclase.
